Navigation Links
Haemostasis in Medical News

Portola Pharmaceuticals Announces Several Scientific Presentations at International Society on Thrombosis and Haemostasis XII Congress

SOUTH SAN FRANCISCO, Calif., July 10 /PRNewswire/ -- Portola Pharmaceuticals, Inc. today announced several scientific presentations at the International Society on Thrombosis and Haemostasis (ISTH) XII Congress in Boston that will feature its investigational antiplatelet drug elinogre...

Bayer HealthCare Awards $2.5 Million to Advance Hemophilia Research and Improve Patient Care

...ernationally recognized experts in hemophilia treatment and care and were honored last evening during the 2009 International Society on Thrombosis and haemostasis (ISTH) Congress in Boston, Massachusetts. "Bayer's continued support of the BHAP program - now in its seventh year - is part of a collaborative a...

Analysis of Four Large Post-Marketing Surveillance Studies Describe Clinical Effects of Sucrose-Formulated Recombinant Factor VIII

...both previously treated and previously untreated patients. The data were presented at the XXII Congress of the International Society on Thrombosis and haemostasis (ISTH).(1)(2) In this analysis, the investigators judged rFVIII-FS hemostasis to be "good" or "very good" in 98.9 percent of patients. Serious a...

Corgenix to Exhibit AspirinWorks(R) Test at 2009 ISTH Meeting

...Works(R) Test at the XXII Congress and the 55th Meeting of the Scientific and Standardization Committee of the International Society on Thrombosis and haemostasis (ISTH). The ISTH 2009 conference is being held July 11-16 at the Boston Convention & Exhibition Center. Corgenix representatives will be on-h...

New Partnerships Added to World Federation of Hemophilia Twinning Program

...ciety for Thrombosis and Haemostasis, which fosters and advances science relating to the important medical problems of thrombosis and abnormalities of haemostasis and vascular biology. Wyeth and Hemophilia Wyeth works to help improve the health of hemophilia patients through education, ...

Research Validates Safety of Dawn AC Anticoagulation Management Software

...ot;...as safe clinically for patients as manual dosage by experienced medical staff," according to an article in a recent issue of Thrombosis and haemostasis (Thromb Haemost 2009; 101:487-494). Led by Professor Leon Poller of the University of Manchester, UK, the scholarly report was authored by a group of ...

Optimal Warfarin Dosing Improves Anticoagulation Control

...have figured out the optimal dosing levels to help patients, according to a study published in December online issue of the Journal of Thrombosis and haemostasis . The research team analyzed warfarin use in almost 4,000 patients to determine what are the most effective levels of the drug in a patient's syste...

Study shows optimal dose management of warfarin improves anticoagulation control

...it from warfarin therapy and improve patient outcomes. Results of the study appear online in the December 2008 issue of the Journal of Thrombosis and haemostasis . Warfarin is highly effective to prevent strokes, treat venous thromboembolism and for other conditions. Numerous studies have focused on the un...

Redesigned protein accelerates blood clotting

...n, dramatically increasing its ability to drive blood clotting, according to a study published in a December edition of the Journal of Thrombosis and haemostasis . The findings have profound implications for the treatment of hemophilia, the inherited blood disorder that causes easy or excessive bleeding in 30,0...

Researchers discover new enzyme in cancer growth

... cancer tumors expand and spread throughout the body. The research appeared in recent issues of the journal Blood and the Journal of Thrombosis and haemostasis . A research group at OU led by Patrick McKee first discovered the enzyme called sFAP in plasma. After studying the biochemical makeup of the prot...
Haemostasis in Medical Technology

Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)

SOUTH SAN FRANCISCO, July 02, 2007 /PRNewswire/ -- Portola Pharmaceuticals, Inc. announced today that it will present clinical and preclinical data on its oral Factor Xa inhibitor and on its intravenous and oral ADP receptor antagonist at the XXI Congress of the International Society of Thrombosis...

Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis

SAN CARLOS, Calif., July 5 /PRNewswire-FirstCall/ -- Nuvelo, Inc. (Nasdaq: NUVO) today announced that data from the ANTHEM (Anticoagulation with rNAPc2 To Help Eliminate MACE)/TIMI 32 Phase 2 trial looking at recombinant nematode anticoagulant protein c2 (rNAPc2) in patients with acute coronary sy...

Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis

SAN FRANCISCO, July 10, 2007 /PRNewswire/ -- Portola Pharmaceuticals, Inc. announced positive Phase II data on its lead compound, PRT054021, an oral Factor Xa inhibitor, today at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Geneva, Switzerland. The EXPERT t...

Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis

HORSHAM, Pa.--(BUSINESS WIRE)--Jul 11, 2007 - Neose Technologies, Inc. (Nasdaq GM:NTEC) today announced that two poster presentations were presented with its collaborative partner, Novo Nordisk A/S, relating to GlycoPEGylated recombinant Factor VIIa at the XXIst Congress of the International Societ...

Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis

RIDGEFIELD, Conn., July 11, 2007 /PRNewswire/ -- Phase 3 results from the RE-NOVATE(TM) trial demonstrated that oral dabigatran etexilate once daily, administered for an average of 33 days, was non-inferior to enoxaparin, also administered for an average of 33 days, in preventing venous thromboemb...

Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing

...gs were presented today at the XXII International Society on Thrombosis and haemostasis Congress in Boston. Edoxaban is being developed solely by Daiichi Sankyo C...ic medicinal products in non-surgical patients. Journal of Thrombosis and haemostasis 2005;3: 692-694. ...

ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402

...of Leuven will present additional data from the earlier successful Phase I studies at the XXII Congress of the International Society on Thrombosis and haemostasis (ISTH) on July 15, 2009 in Boston. Patrik De Haes, CEO of ThromboGenics commented, "We are very happy that this important study with TB-402 is ...

Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes

... Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that ma...

New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation

...t al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. Journal of Thrombosis and haemostasis 2005;3: 692-694. 2. Jorgensen, H.S., Nakayama, H, Reith, J. et. al. Acute stroke with atrial fibrillation. Stroke 1996;27: 1765-1769. ...

New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes

...ncluding the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that ma...

More>>

Haemostasis in Medical Products

FLOSEAL

Description:...stasis, clinically proven to control bleeding from capillary oozing to arterial spurting. FloSeal is indicated in surgical procedures as an adjunct to haemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
Company:Baxter Healthcare

ST art

Description:... A complete workstation for haemostasis A compact and convenient analyser A comprehensive system An exellent reliability: the STAGO patented detection mode...
Company:Roche Diagnostics
Haemostasis in Medical Dictionary

Hemostasis

... Hemostasis or haemostasis is a complex process which causes the bleeding process to stop. Most time...ut hemostasis in the free online English dictionary and ... hemostasis , haemostasis ... Hemostasis gel by Ear, Nose and Throat Journal ... It is an impor...
Haemostasis in Biological News

'Molecular assassin' targets disease gene

...t focusing on a different master regulator, Egr-1, has also been published this month by Professor Khachigian's group in the Journal of Thrombosis and haemostasis and shows that heart muscle damage is reduced by the drug after a heart attack. ...

Promising therapies for haemophilia & heart disease

...rnative treatment option for haemophilia sufferers. Presenting this research, at the XXth Congress of the International Society on Thrombosis & haemostasis in Sydney today, Wagner said, "We have demonstrated that a protein called P-selectin is important for blood clotting and altering its levels in the bl...
Haemostasis in Biological Technology

Inspiration Biopharmaceuticals Presents Safety Data on IB1001, a Novel Recombinant Factor IX for the Treatment of Hemophilia at the International Society on Thrombosis and Haemostasis (ISTH) Annual Meeting

LAGUNA NIGUEL, Calif., July 14 /PRNewswire/ -- Inspiration Biopharmaceuticals today announced the presentation of positive preclinical safety, toxicology and preliminary pharmacokinetic data on its lead product, IB1001, a novel recombinant Factor IX product to treat patients with he...

Regado Biosciences' REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemostasis

Phase 1c Study Demonstrates Dose-dependent Activity of Antidote Component DURHAM, N.C., May 14 /PRNewswire/ -- Regado Biosciences today announced the Journal of Thrombosis and Haemostasis, the official journal of the International Society on Thrombosis and Haemostasis, has published the Phase 1...

Instrumentation Laboratory to Announce 'Passion & Results' Award Winners

...nounced it will present the "Passion & Results" Award to three recipients at the upcoming Congress for the International Society on Thrombosis and haemostasis (ISTH) and at the Annual Meeting for the American Association for Clinical Chemistry (AACC), held in Boston, MA on July 11-16 and Chicago, IL on July ...
Other Tags
(Date:12/26/2014)... 26, 2014 DW-InductionHeating.com (DaWei Induction Heating ... researching and developing, producing and marketing of a series ... business announces their new series of induction brazing ... the company, induction brazing refers to the ... filler material and heat. The manager says that there ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 ... Market Analysis to 2023” focuses on the current ... opportunities in the colorectal cancer market. Stivarga is ... of colon or rectal cancer. Boehringer Ingelheim is ... for the treatment of refractory CRC in the ...
(Date:12/25/2014)... December 26, 2014 Recently, Dylan Queen, ... has excitedly released its collection of discounted prom dresses, ... Percy, a senior spokesman of the company, the promotion ... this promotion is to expand the UK market. , ... several different colors, lengths, and styles: A-line strapless, empire ...
(Date:12/25/2014)... When head lice hits a home or ... to get rid of it while keeping it from taking ... now have the solution right in their neighborhood: Lice ... Troopers provides full spectrum head lice screening and treatment services ... Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest and South ...
(Date:12/25/2014)... 2014 (HealthDay News) -- Among early stage breast cancer ... half of one percent will eventually develop leukemia as ... The finding comes from a review of more ... 2007, and it suggests that the risk for developing ... had previously thought. "The frequency of bone marrow ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... addition of the "Global Facial Recognition Market ... http://photos.prnewswire.com/prnh/20130307/600769 Facial ... of individuals. Facial recognition system measures the overall ... jaw edges, mouth, and the distance between eyes. ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has ... in India 2015-2019" report to their offering. ... this market is the adoption of multimodal biometric ... characteristic of an individual for verification and identification ...
(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences ... monitoring, has released a new series of digital ... preclinical toxicology researchers. M series, part of the ... collect the best possible physiologic data when incorporating ... Adding functional endpoints to toxicology studies has evolved ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
Other Contents